BCI
SIOX

Brinker Capital Investments’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Brinker Capital Investments’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2
Closed – – 763
2015
Q3 		$0 Buy
+2
New +$235 ﹤0.01% 526

Other funds holding SIOX

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Brinker Capital Investments's SIOX Position: Q4 2015 in Review

Brinker Capital Investments sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2015, closing a stake of 2 shares.

Brinker Capital Investments first reported a position in SIOX in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 70 funds tracked by Wall St. Rank hold SIOX as of Q4 2015.

  • Brinker Capital Investments reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Brinker Capital Investments sold 2 Sio Gene Therapies Inc. Common Stock shares in Q4 2015.
  • Brinker Capital Investments first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Brinker Capital Investments's Sio Gene Therapies Inc. Common Stock position peaked at $0 in Q3 2015.
  • 70 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2015.

Based on Brinker Capital Investments's 13F filing for Q4 2015, filed 11 Feb 2016.